Chinese scientists reveal the feasibility, tolerability, and efficacy of BCMA-CD19 bispecific CAR T-cells for treating chronic inflammatory demyelinating polyneuropathy (CIDP) and highlight the potential of CAR-T cell therapy ...
Jun 20, 2024
0
1
A team led by investigators from Massachusetts General Hospital used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting ...
May 17, 2024
0
36
Fifty-six years after the first human-to-human heart transplantation, more than 5,000 hearts are transplanted each year around the world. This number is far from enough to give a new heart to everyone who needs one, with ...
Apr 5, 2024
0
17
The prognosis for the sick child, who hadn't responded to standard treatment, was dire. But a team of Rutgers physicians believed there might be hope despite the conventional wisdom against pursuing any further treatment.
Oct 27, 2022
0
39
A decade-spanning trial found that for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, two common methods of treatment actually do not have an impact on their long-term survival. The study, ...
Feb 12, 2020
0
5
(HealthDay)—A case of hepatitis E virus (HEV) infection has been reported in a kidney transplant recipient, according to a research letter published online March 1 in the Annals of Internal Medicine.
Mar 2, 2016
0
0
(Medical Xpress)—Two clinical studies have shown that the monoclonal antibody eculizumab is effective in treating patients with atypical hemolytic uremic syndrome (aHUS), a life-threatening, chronic, and progressive inflammatory ...
Jun 6, 2013
0
0
